⌘K
Loading ticker…
Immucell Corp · Healthcare · Pharmaceutical Products
As of 2026-06-26, Immucell Corp (ICCC) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 68. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.2%, relative volume 1.11×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 89, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ICCC is in a stage 2 uptrend, week 9. Currently in a 21-day base; basing ADR 4.3% (broad 4.1%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 6.7% / 41.3%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
ICCC is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M |
| VXFVanguard Extended Market ETF | 0.00% | $502K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ICCC Jan avg: 7.17% median: 4.54% win: 75% σ: 10.19% n: 4 2022-04-12 → 2026-05-29 | ICCC Feb avg: -3.52% median: -1.35% win: 25% σ: 12.38% n: 4 2022-04-12 → 2026-05-29 | ICCC Mar avg: -6.30% median: -6.47% win: 25% σ: 5.79% n: 4 2022-04-12 → 2026-05-29 | ICCC Apr avg: 8.06% median: 5.40% win: 60% σ: 16.47% n: 5 2022-04-12 → 2026-05-29 | ICCC May avg: 1.18% median: -3.05% win: 40% σ: 17.55% n: 5 2022-04-12 → 2026-05-29 | ICCC Jun avg: 8.71% median: 7.95% win: 100% σ: 3.95% n: 4 2022-04-12 → 2026-05-29 (current) | ICCC Jul avg: -3.78% median: -3.72% win: 50% σ: 10.88% n: 4 2022-04-12 → 2026-05-29 | ICCC Aug avg: -9.87% median: -11.49% win: 25% σ: 7.93% n: 4 2022-04-12 → 2026-05-29 | ICCC Sep avg: 3.29% median: 0.13% win: 50% σ: 8.72% n: 4 2022-04-12 → 2026-05-29 | ICCC Oct avg: 0.23% median: -0.36% win: 25% σ: 5.16% n: 4 2022-04-12 → 2026-05-29 | ICCC Nov avg: -8.06% median: -11.98% win: 25% σ: 15.67% n: 4 2022-04-12 → 2026-05-29 | ICCC Dec avg: 13.15% median: 18.56% win: 75% σ: 17.77% n: 4 2022-04-12 → 2026-05-29 |